Amexdrug Stock Net Income
| AXRXDelisted Stock | USD 0.0002 0.00 0.00% |
Amexdrug technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amexdrug's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amexdrug's valuation are provided below:Amexdrug does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Amexdrug |
Search Suggestions
| AX | Axos Financial | Company |
| AXS-PE | AXIS Capital Holdings | Company |
| AXBIX | Intermediate Term Tax Free Bond | Mutual Fund |
| AXDI | BlackRock | ETF |
| AXS | Axie Infinity Shards | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Amexdrug reported net income of 111.36 K. This is 99.97% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.98% higher than that of the company.
Amexdrug Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amexdrug's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amexdrug could also be used in its relative valuation, which is a method of valuing Amexdrug by comparing valuation metrics of similar companies.Amexdrug is currently under evaluation in net income category among its peers.
Amexdrug Fundamentals
| Return On Equity | 0.29 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 34.51 M | |||
| Shares Outstanding | 169.11 M | |||
| Price To Earning | 165.00 X | |||
| Price To Book | 51.38 X | |||
| Price To Sales | 3.04 X | |||
| Revenue | 10.43 M | |||
| Gross Profit | 1.01 M | |||
| EBITDA | 380.83 K | |||
| Net Income | 111.36 K | |||
| Cash And Equivalents | 168.01 K | |||
| Total Debt | 961.12 K | |||
| Debt To Equity | 1.46 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | 27.49 K | |||
| Beta | -0.72 | |||
| Market Capitalization | 16.91 M | |||
| Total Asset | 2.31 M | |||
| Retained Earnings | 961 K | |||
| Working Capital | 966 K | |||
| Current Asset | 1.76 M | |||
| Current Liabilities | 798 K | |||
| Z Score | 14.2 | |||
| Net Asset | 2.31 M |
About Amexdrug Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amexdrug's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amexdrug using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amexdrug based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Amexdrug Pink Sheet
If you are still planning to invest in Amexdrug check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amexdrug's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |